Mission
Advance the mission of the Food and Drug Administration to modernize product development, accelerate innovation, and enhance product safety.
Public Charity
Reagan-Udall Foundation for the Food and Drug Administration Inc
Based in Washington, DC, Reagan-Udall Foundation for the Food and Drug Administration Inc operates as a Public Charity. The organization reported $8.7M in revenue, $8.9M in expenses, $6.0M in total assets for fiscal year 2025. Imperigo tracks 21 reported grant relationships connected to this organization totaling approximately $453K.
EIN: 263727917
Washington, DC
Latest filing: 2025
Total Revenue$8.7M
Total Expenses$8.9M
Total Assets$6.0M
Grant Records21
Funding Total$453K
Filing Years2021–2025
Where $100 goes at Reagan-Udall Foundation for the Food and Drug Administration Inc
How Reagan-Udall Foundation for the Food and Drug Administration Inc divides every $100 it spends, from its own Form 990 filings, averaged across 9 years.
$93
Programs
the work itself
$4
Management
running the organization
$3
Fundraising
raising the next dollar
Inside the $93 for programs
$52
Advancing Regulatory Science
$25
Supporting Development and Dissemination of Reliable Information- Improve public understanding of the risks and benefits of FDA-regulated products
$16
Facilitating Engagement and Information Exchange
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
GENERAL CONTRIBUTION
$50,000
ANNUAL INNOVATIONS IN REGULATORY SCIENCE AWARDS - SPONSORSHIP
$15,000
General Contribution
$30,000
2023 INNOVATIONS IN REGULATORY SCIENCE AWARDS CELEBRATION SPONSORSHIP
$15,000
NATIONAL HEALTH COUNCIL 2023 DUES
$8,000
Showing up to 5 of 21 total records — full history available with membership.
Officers & Directors
Board Vice Chair
Adrian F Hernandez
Chief Operating Officer
Amar Bhat Phd
Director
Andrew C Von Eschenbach
Director, Research
Carla Rodriguez-Watson Phd
Director
Christie Boutte
Director
David C Fajgenbaum
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $8.7M | $8.9M | $6.0M |
| 2024 | $8.2M | $7.9M | $7.2M |
| 2023 | $8.2M | $7.8M | $6.4M |
| 2022 | $8.8M | $8.6M | $8.1M |
| 2021 | $5.4M | $5.3M | $4.9M |
Between 2021 and 2025, reported annual revenue grew from $5.4M to $8.7M (+60%), with total assets most recently reported at $6.0M.
Interactive year-over-year charts and full filing details available with membership.